Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Drug Interaction Study Evaluating the Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol
Conditions
Interventions
SOF/VEL/VOX
VOX
+1 more
Locations
1
New Zealand
Christchurch, New Zealand
Start Date
October 29, 2015
Primary Completion Date
March 18, 2016
Completion Date
March 18, 2016
Last Updated
September 2, 2020
NCT06928259
NCT05992077
NCT05534633
NCT07412977
NCT07241962
NCT04134767
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions